ERBB2 and breast cancer: Interestingly, the clinical study with the use of microwave ablation (MWA), a non-invasive, local BC treatment option, has shown that MWA increases the percentage of ICOS-expressing CD4+ T cells concomitantly shifting the immunological response to Th1 in HER2+ BC and TNBC subtypes [162].